Methyl 4-cyano-3-nitrobenzoate, 97%, 5g

(4-Aminopyridin-2-yl)methanol, 95.0%, 250mg

(2S)-2-AMINO-2-(3,4-DIFLUOROPHENYL)ACETIC ACID, 95.0%, 500mg

6-Oxo-1,4,5,6-tetrahydro-pyridazine-3-carboxylic acid, 97.0%, 25g

(S)-3-hydroxypiperidin-2-one, 98%, 250mg

N,N-diisopropiletilamina, PEPTIPURE®, minimo 99,5%, per la sintesi di peptidi, 1 l

3-[(2-Methylpropan-2-yl)oxycarbonyl]-3-azabicyclo[3.2.0]heptane-5-carboxylic acid, 95+%, 250mg

Methyl 1,2,3,4-tetrahydroisoquinoline-1-carboxylate hydrochloride, 95%, 25g

2,5-Difluoro-nicotinic acid, 95.0%, 250mg

[4-(4-Methoxy-phenyl)-pyrimidin-2-ylsulfanyl]-acetic acid hydrazide, 5g

2-Chloro-4-formyl-3-methylphenylboronic acid, 98+%, 500mg

(3-Bromopyridin-4-yl)methanamine dihydrochloride, 97%, 250mg

2-Bromo-5-iodo-3-methylpyridine>96.0%(GC)1g